Influenza A viruses are zoonotic viruses that can infect multiple hosts in nature, including birds, pigs, dogs, horses and humans. These viruses undergo substantial and constant reassortment in wild hosts, leading to the permanent possibility of the emergence of novel strains with epidemic or pandemic potential in humans. Human cases of infection with the highly pathogenic avian influenza virus carrying the H5 subtype of haemagglutinin (HA) and the N1 subtype of neuraminidinase (NA) (H5N1) continue to occur throughout parts of East and Southeast Asia, the Middle East, Africa and Europe. Outbreaks of H7 and H9 viruses in poultry and zoonotic infections of humans with these viral strains, as well as the emergence in 2009 of a pandemic H1N1 strain that originated in pigs, revealed the need and the value of systematic surveillance of susceptible hosts. Several viral adaptations are required for efficient infection, replication and transmission in a new host. In addition, several virus–host interactions modulate infection, and disease severity is a consequence of viral virulence determinants and host-specific responses to infection. Thus, the pathogenesis of influenza A viruses is multifactorial and host specific. The level of pre-existing immunity in the general population is a major determinant of pathogenesis. The emergence of antigenically novel viruses as a result of immune selection pressure leads to regular epidemics. In addition, the acquisition (through reassortment) of a novel HA subtype or an HA that is antigenically similar to older strains but to which a large proportion of the population is naive (as was the case with the 2009 pandemic H1N1 strain) can lead to the emergence of a pandemic virus. In humans, several underlying risk factors for infection have been identified. These include obesity, diabetes, cardiovascular disease, chronic lung disease (including asthma), pregnancy, old age, young age (<2 years) and being immunocompromised. Carefully designed clinical studies to elucidate the contribution of genetic susceptibility factors and polymorphisms, as well as to further define human susceptibility factors, are key for improving our understanding of the host determinants of influenza virus pathogenesis.